Pharmacogenomics (also referred to as pharmacogenetics, or PGx) is a field of study combining the science of pharmacology and genomics and explores how an individual’s genetics may influence their response to drugs.
PGx is one aspect of precision medicine – a model that emphasises personalised care plans based on specific patient characteristics, such as one’s genotype. In that way, pharmacogenetic testing may provide additional evidence and insight into medication response variability. PGx testing is utilised as an informative tool when considering treatment options or individualising dosing.
This field cannot determine “the perfect drug.” However, in conjunction with clinical judgment and reviewing the patient’s current symptoms, past treatment response, family history and treatment goals, clinicians can utilise PGx to make more robust and informed treatment decisions for their patients.
Understand more about your patient to make precision treatment a standard of care.
Find out how the test works, and how to start offering the Psychiatric
Pharmacogenetic (PGx) Test to your patients
We make it easy to personalise treatment and prevent interactions risk. Myogenes handles the billing process with your patient or
practice from start to finish. Learn more about what your patient can expect.
Our Precision Medicine Software is a powerful solution that can be used
at the point of care to help optimise prescribing decisions.
Find out how the test works, and how to start offering the Psychiatric
Pharmacogenetic (PGx) Test to your patients
Want to know more about the Psychiatric Genetic Test?
Fill out your email address and download the sample report today.
Myogenes Limited is a company
Registered in England and Wales.
Company Number 10399052
Tel: 020 8387 1266
Email: info@myogenes.com
Myogenes Ltd
Kinetic Business Centre
Theobald Street
Borehamwood
WD6 4PJ
United Kingdom